Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-09

Clinical Trial Update: Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing RPL554 with placebo and salbutamol in asthmatic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RPL554 (RPL554)
  • Salbutamol (salbutamol)

Snippet

Sponsor: Verona Pharma plc | Conditions: Asthma | Phase 2 | Status: COMPLETED